Boston Therapeutics, Inc. Business Finance Contracts & Agreements
68 Contracts & Agreements
- Assignment Agreements (3 contracts)
- Contribution Agreements (1)
- Debenture Agreements (1)
- Exchange Agreements (3)
- Guaranty Agreements (1)
- Note Agreements (13)
- Purchase Agreements (12)
- Registration Rights Agreements (3)
- Security Agreements (1)
- Stock Agreements (9)
- Subscription Agreements (5)
- Waiver Agreements (2)
- Warrant Agreements (14)
- Subscription Agreement, dated October 21, 2022, by and between the Company and the Investor (Filed With SEC on November 10, 2022)
- Form of Warrant, dated March 23, 2022 (Filed With SEC on March 24, 2022)
- Securities Purchase Agreement, dated March 23, 2022 (Filed With SEC on March 24, 2022)
- Consent, Amendment and Waiver, dated March 22, 2022 (Filed With SEC on March 24, 2022)
- Form of Senior Secured Convertible Note, dated February 28, 2022 (Filed With SEC on March 1, 2022)
- Form of Warrant, dated February 28, 2022 (Filed With SEC on March 1, 2022)
- Securities Purchase Agreement, dated February 28, 2022 (Filed With SEC on March 1, 2022)
- Consent, Amendment and Waiver, dated February 24, 2022 (Filed With SEC on March 1, 2022)
- Form of Senior Secured Convertible Note, dated June 25, 2021 (Filed With SEC on June 29, 2021)
- Form of Warrant, dated June 25, 2021 (Filed With SEC on June 29, 2021)
- Securities Purchase Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc. and the buyers signatory thereto (Filed With SEC on June 29, 2021)
- Registration Rights Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc. and the buyers signatory thereto (Filed With SEC on June 29, 2021)
- Security and Pledge Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc, each of the Companys subsidiaries and HT Investments MA LLC, in its capacity as... (Filed With SEC on June 29, 2021)
- Guaranty, dated June 25, 2021, by each of the Companys subsidiaries in favor of HT Investments MA LLC, in its capacity as collateral agent (Filed With SEC on June 29, 2021)
- Form of Exchange Agreement, dated June 25, 2021, with existing holders of convertible promissory notes (Filed With SEC on June 29, 2021)
- Form of Promissory Note dated April 30, 2021 (Filed With SEC on May 12, 2021)
- Form of 10% Promissory Note issued by Nanomix, Inc. to Boston Therapeutics Inc (Filed With SEC on May 12, 2021)
- Certificate of Designation Series B Preferred Stock (Filed With SEC on February 2, 2021)
- Form of Exchange Agreement (Filed With SEC on February 2, 2021)
- Form of Promissory Note dated June 12, 2018 (Filed With SEC on June 14, 2018)
- Form of Contribution Agreement between Boston Therapeutics, Inc., CureDM Group, LLC and the members of CureDM Group Holdings, LLC dated January 1, 2018 (Filed With SEC on February 12, 2018)
- Form of Securities Purchase Agreement entered between Boston Therapeutics, Inc. dated August 14, 2017 (Filed With SEC on August 22, 2017)
- Form of Common Stock Purchase Warrant issued to the Investors (Filed With SEC on August 22, 2017)
- Securities Purchase Agreement entered between Boston Therapeutics, Inc. and CJY Holdings Limited (Filed With SEC on May 2, 2017)
- Form of 6% Subordinated Convertible Debenture (Filed With SEC on May 2, 2017)
- Form of Stock Purchase Warrants (Filed With SEC on May 2, 2017)
- Form of Securities Purchase Agreement entered with the August 2016 Accredited Investors (Filed With SEC on August 15, 2016)
- Form of Stock Purchase Warrant (Filed With SEC on August 15, 2016)
- Warrant Repricing and Exercise Agreement entered by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated November 12, 2015, effective June 15, 2015 (Filed With SEC on November 12, 2015)
- Form of Securities Purchase Agreement by and between Boston Therapeutics, Inc. and CJY Holdings Limited (Filed With SEC on October 2, 2015)
- Form of 10% Convertible Promissory Note issued to CJY Holdings Limited (Filed With SEC on October 2, 2015)
- Securities Purchase Agreement between Boston Therapeutics, Inc. and JDF Capital, Inc. dated as of March 13, 2015 (Filed With SEC on May 20, 2015)
- Convertible Promissory Note between Boston Therapeutics, Inc. and JDF Capital, Inc. dated as of March 13, 2015 (Filed With SEC on May 20, 2015)
- Convertible Note between Boston Therapeutics, Inc. and JMJ Financial dated as of March 18, 2015 (Filed With SEC on May 20, 2015)
- Securities Purchase Agreement between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated as of March 16, 2015 (Filed With SEC on May 20, 2015)
- Convertible Promissory Note between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated as of March 16, 2015 (Filed With SEC on May 20, 2015)
- Securities Purchase Agreement between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015 (Filed With SEC on May 20, 2015)
- Convertible Promissory Note between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015 (Filed With SEC on May 20, 2015)
- Warrant to Purchase Shares of Common Stock between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015 (Filed With SEC on May 20, 2015)
- Form of Warrant issued to investors in this offering (Filed With SEC on April 28, 2015)
